SOLENO THERAPEUTICS INC Interest Expense Nonoperating
SOLENO THERAPEUTICS INC reported Interest Expense Nonoperating of $1.29 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-05-07
- SOLENO THERAPEUTICS INC interest expense nonoperating for the quarter ending 2026-03-31 was $1.29M, a 5.07% decline year-over-year.
- SOLENO THERAPEUTICS INC interest expense nonoperating for the quarter ending 2025-12-31 was $1.35M.
- SOLENO THERAPEUTICS INC interest expense nonoperating for the quarter ending 2025-09-30 was $1.39M.
- SOLENO THERAPEUTICS INC interest expense nonoperating for the quarter ending 2025-06-30 was $1.38M.
- SOLENO THERAPEUTICS INC interest expense nonoperating for fiscal 2025 was $5.48M, a 2270.56% increase from fiscal 2024.
- SOLENO THERAPEUTICS INC interest expense nonoperating for fiscal 2024 was $231.00K.
- SOLENO THERAPEUTICS INC interest expense nonoperating for fiscal 2023 was $0.00.
- SOLENO THERAPEUTICS INC interest expense nonoperating for fiscal 2022 was $0.00.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-03-31 | $1.29M 10-Q · filed 2026-05-07 | $2.64M derived: sum of 2 quarters · filed 2026-05-07 | $4.03M derived: sum of 3 quarters · filed 2026-05-07 | $5.41M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.74M derived: sum of 2 quarters · filed 2026-02-25 | $4.12M derived: sum of 3 quarters · filed 2026-02-25 | $5.48M 10-K · filed 2026-02-25 |
| 2025-09-30 | $1.39M 10-Q · filed 2025-11-04 | $2.77M derived: sum of 2 quarters · filed 2025-11-04 | $4.13M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $1.38M 10-Q · filed 2025-08-06 | $2.74M 10-Q · filed 2025-08-06 | ||
| 2025-03-31 | $1.36M 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | $231.00K 10-K · filed 2026-02-25 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-02-28 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-28 |